Ireland Senate Passes Bill to Raise Legal Age for Tobacco Sales to 21

Nov.08.2024
Ireland Senate Passes Bill to Raise Legal Age for Tobacco Sales to 21
The Irish Senate has passed the Public Health (Tobacco) (Amendment) Bill, raising the legal minimum age for the sale of tobacco products to 21.

According to Irish Central, on November 7th, the Irish Senate passed the Public Health (Tobacco) (Amendment) Bill for 2024, completing its legislative process in both houses of parliament. The bill will raise the minimum legal age for the sale of tobacco products to 21. The bill is now set to be submitted to the President for review and signing.

 

After the president signs, the law will take effect on February 1, 2028. The transition period before this is designed to ensure individuals currently aged between 18 and 21 who are eligible to purchase tobacco will not be affected.

 

The bill stipulates that current penalties will be expanded to include punishments for selling tobacco products to individuals under the age of 21. First-time offenders can be fined up to a maximum of 4000 euros or face six months in prison, or both.

 

Ireland's Department of Health said that this measure aims to accelerate the decline in adult smoking prevalence, which have remained at 18% for many years, and reduce child smoking rates to zero. 

 

If the bill is passed, Ireland will become the first country in the European Union to raise the legal age for tobacco sales to 21.

 

"Ireland has long been a world leader in tackling smoking, beginning with the workplace smoking ban in 2004 and continuing with a range of measures including restrictions around the sale, advertising and packaging of smoking products to make them less attractive and less available to young people," Ireland's Minister for Health Stephen Donnelly said.

 

"I look forward to seeing this measure enacted, to help our young people to avoid the lifetime of addiction and illness that tobacco smoking brings," he said.

 

Minister of State Colm Burke, responsible for public health and national drug strategy, said: "This measure will protect our young people from starting their adult lives with an addiction to a product that causes 76% of lung cancers here and kills half of those who use it.

 

"I have strongly supported its introduction from the beginning and I look forward to its enactment."

 

Ireland's Chief Medical Officer, Professor Mary Hogan, said: "The enactment of this legislation represents another significant step in our efforts to reduce smoking levels."

 

"Tobacco smoking continues to be the biggest risk factor driving disability and death combined in our country, placing a huge burden on our health service."

 

"This measure will contribute to eliminating that ongoing threat and will support people to follow healthier behaviours."

 

In December 2023, Donnelly commenced section 28 of the Public Health (Tobacco Products and Nicotine Inhaling Products) Act to prohibit the sale of nicotine-inhaling products such as e-cigarettes (commonly referred to as vapes) to persons under 18.

 

In May 2024, Donnelly implemented parts of the bill that banned the sale of tobacco and nicotine inhalation products through vending machines. In December, he signed a law imposing on-the-spot fines of 2,000 euros for the sale of such products to children. 

 

In addition, Northern Ireland Health Minister Mike Nesbitt has welcomed the introduction of the Tobacco and Vapes Bill at Westminster this week. The bill prohibits anyone born on or after January 1, 2009 will never be able to legally be sold cigarettes, but its implementation in Northern Ireland will be subject to the agreement of the NI Executive and support of the NI Assembly.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02
Product | Geek Bar Expands Meloso Lineup With the Launch of Meloso Max 2
Product | Geek Bar Expands Meloso Lineup With the Launch of Meloso Max 2
Geek Bar has added Meloso Max 2 to its official product lineup, further expanding its disposable vape portfolio. As the latest generation of the Meloso series, the new device introduces upgrades in endurance, device interaction and industrial design while reinforcing Geek Bar’s strategy of offering differentiated disposable products across multiple usage scenarios.
Jun.26
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts held a U.S. compliance briefing in Shenzhen to help vaping, heated tobacco and nicotine pouch supply chain companies strengthen PMTA support capabilities. The event focused on supplier documentation, quality systems, traceability, TPMF/TPMP pathways, age verification and customer audit readiness as U.S. compliance expectations increasingly extend deeper into the nicotine supply chain.
Events
Jun.12
EU Launches Online Feedback as TPD Revision Enters New Milestone
EU Launches Online Feedback as TPD Revision Enters New Milestone
The European Commission has opened an online call for evidence on revising EU tobacco products and advertising rules, marking a new phase in the TPD/TAD review. Policy options may cover novel products, flavours, packaging, digital marketing and advertising. A 2Firsts review of 855 early submissions shows rapid engagement and recurring debate over differentiated regulation, harm reduction, youth protection, illicit trade and economic impact.
Special Report
May.21
  South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea’s cigarette tax debate has resurfaced after the Ministry of Health and Welfare said tobacco price policy needed review, with a poll showing 63% of respondents support higher tobacco taxes.
Regulations
Jun.22